REVIEW article
Front. Cell. Infect. Microbiol.
Sec. Microbial Vaccines
Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1638997
This article is part of the Research TopicAdvanced Biotechnology and Nanotechnology in Theragnostic of Infectious Lung DiseasesView all 4 articles
Advances in Diagnosis and Treatment of Lung Cancer-Associated Obstructive Pneumonia and Lung Abscess: Synergistic Strategies for Infection Control and Antitumor Therapy
Provisionally accepted- Sichuan Cancer Hospital and Institute, Chengdu, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Lung cancer-associated obstructive pneumonia and pulmonary abscess represent critical oncologic complications. Effective management hinges on dynamically balancing primary tumor control with secondary infection management. Recent major advances in targeted therapy, immunotherapy, and novel anti-infective technologies have driven a shift towards integrated, multidimensional clinical strategies.This review details diagnostic and therapeutic progress for these conditions, emphasizing the critical balance between controlling severe infections and managing antitumor therapy toxicities, alongside recent advances in nanomedicine for pulmonary infections.
Keywords: Advanced lung cancer, Obstructive pneumonia, Pulmonary abscess, Nanomedicine, Antimicrobial therapy
Received: 01 Jun 2025; Accepted: 24 Sep 2025.
Copyright: © 2025 Cao, Chen, Xie and Hu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Shaohua Xie, xieshaohua2009@163.com
Bin Hu, hubin@scszlyy.org.cn
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.